Investor centre

Investor Centre.
Results, reports and disclosures.

Quarterly results, investor presentations, annual reports and statutory disclosures of Morepen Laboratories Limited.

Selected publication

First U.S. ANDA submission expands integrated development

28 SEP 2026 · Connecting API knowledge with finished-dose development and regulatory filing.

Open official document

The source document opens in a new tab. The official investor archive remains below.

Q1 FY27 performance

Recent performance.
At a glance.

Open Q1 FY27 presentation

5,753 INR million

Revenue

Highest-ever quarterly revenue

877 INR million

EBITDA

Highest-ever quarterly EBITDA - 3x YoY

8,250 INR million

CDMO mandate

Entered commercial supplies

15.25%

EBITDA margin

Blended EBITDA improves

+111%

Export growth

Prioritisation of customer mix

19%

Medical Devices growth

Maintains strong growth

Investor library

Everything else.
Compact and structured.

Important contacts

Investor & shareholder
contact directory.

Registrar & Share Transfer Agent

MAS Services Limited
T-34, 2nd Floor, Okhla Industrial Area,
Phase-II, New Delhi-110020
011-26387281/82/83
investor@masserv.com

Nodal Officer for IEPF matters

Chief Financial Officer

Ajay Kumar Sharma
2nd Floor, Tower C, DLF Cyber Park,
Udyog Vihar
Sector -20, Gurugram, Haryana - 122016
0124-4892000
investors@morepen.com

Stay close to the published record.

Recent presentations and annual reports lead the experience; all other investor information remains clearly organised behind them.

Talk to our team

Investor Centre.Results, reports and disclosures.